Call Us Now
 
Facebook-f Instagram Linkedin-in
CONTACT US
LOGIN

Ophthalmic Suspension Manufacturer in Nagpur: Specialized Sterile Eye-Care Formulations

Ophthalmic Suspension Manufacturing for Nagpur's Healthcare Market

Nagpur serves as an important healthcare and pharmaceutical centre with hospitals, specialist clinics, pharmacies and distribution networks supporting patients across the region. Within this environment, ophthalmic products from EyeKare Kilitch require careful formulation, controlled manufacturing and dependable quality systems because they are administered directly to the eye. Suspension-based ophthalmic products represent a specialized dosage form that needs appropriate product development and manufacturing expertise. 

EyeKare Kilitch has a dedicated ophthalmology portfolio that includes multiple suspension products. Its official product catalogue lists TwoBrieye as Brinzolamide & Brimonidine Tartrate Ophthalmic Suspension, NEPEYE OD as Nepafenac Ophthalmic Suspension, and MOXIEYE-LP GEL as Loteprednol-Etabonate & Moxifloxacin Ophthalmic Suspension. For organizations researching Ophthalmic Suspension Manufacturer in Nagpur, this product breadth demonstrates EyeKare’s presence across specialized suspension formulations.

Understanding Ophthalmic Suspensions

An ophthalmic suspension contains active pharmaceutical ingredients that are formulated as dispersed particles within a liquid vehicle rather than being completely dissolved. This makes formulation design, particle characteristics, uniformity and product handling important considerations. Depending on the medicine, the suspension may require shaking before use so that the formulation is adequately redispersed. 

EyeKare’s portfolio includes suspensions across different therapeutic categories, demonstrating that the company works with more than one type of ophthalmic suspension. TwoBrieye is identified as a sterile ophthalmic suspension with no preservatives, while NEPEYE OD is listed as a sterile ophthalmic suspension containing Nepafenac 0.3% w/v.

TwoBrieye: Preservative-Free Ophthalmic Suspension

TwoBrieye is listed by EyeKare as Brinzolamide & Brimonidine Tartrate Ophthalmic Suspension. The product catalogue describes it as a no-preservatives sterile ophthalmic suspension. Its composition is listed as Brinzolamide IP 1% w/v and Brimonidine Tartrate IP equivalent to Brimonidine 0.2% w/v, with Water for Injections IP q.s.  

This product provides an example of the formulation complexity involved in ophthalmic suspension manufacturing. A combination product requires accurate control of the individual active ingredients as well as the overall suspension system. For procurement teams, composition, concentration, preservative status, packaging and approved product documentation are useful specifications to evaluate. 

NEPEYE OD: Nepafenac Ophthalmic Suspension

NEPEYE OD is another suspension listed in EyeKare’s product portfolio. The official catalogue identifies it as Nepafenac Ophthalmic Suspension IP 0.3% w/v and specifies a sterile ophthalmic suspension. This gives businesses a clearly defined non-combination suspension formulation to consider when reviewing EyeKare’s manufacturing portfolio.  

A product such as NEPEYE OD also illustrates why suspension manufacturing requires attention to formulation consistency and product handling. Procurement teams should review the complete approved composition, dosage instructions, storage requirements and packaging information rather than evaluating a suspension only by its active ingredient. 

Moxifloxacin and Loteprednol Suspension Formulation

EyeKare’s catalogue also lists MOXIEYE-LP GEL, described as Loteprednol-Etabonate & Moxifloxacin Ophthalmic Suspension. This combination brings an antibiotic and corticosteroid into a specialized ophthalmic formulation and further expands the company’s suspension portfolio. 

For businesses evaluating a manufacturer, a portfolio containing different suspension types can be useful because it demonstrates experience across distinct active ingredients and formulation requirements. Each product, however, should be assessed independently according to its composition, approved indications, packaging and quality documentation. 

Why Manufacturing Expertise Matters for Ophthalmic Suspensions

Ophthalmic manufacturing requires high attention to sterility, formulation accuracy, contamination control and packaging because products are applied directly to sensitive ocular tissues. EyeKare states that its products are manufactured in-house in a facility spread across 3,50,000 square feet and describes the facility as compliant with international standards. 

The company also highlights more than 50 qualified scientists working in research and development and quality control. Its stated mission is to offer quality innovative products through in-house development and manufacturing excellence for the ophthalmic sector. These capabilities are relevant considerations when organizations assess an ophthalmic suspension manufacturing partner. 

Key Factors to Evaluate in an Ophthalmic Suspension Manufacturer

Formulation Capability 

Suspension products require suitable formulation development and control of characteristics that affect dispersion and product consistency. A manufacturer should be evaluated on its ability to develop and produce the specific suspension required rather than only on its general eye-drop manufacturing capacity. 

Sterility and Quality Systems 

Sterility and contamination control are fundamental considerations for ophthalmic products. Quality systems, process controls, documentation and validation practices should be reviewed as part of a supplier assessment. 

Packaging and Product Handling 

The container and dispensing system are also important. Businesses should review the product’s packaging, storage conditions, shelf life and instructions such as shaking before use where applicable. These details should come from the current approved product information. 

EyeKare's Specialized Ophthalmic Portfolio

EyeKare describes itself as deeply committed to ophthalmology and offers products across therapeutic areas including anti-glaucoma, antibiotic, antibiotic plus NSAID, antibiotic plus steroid, lubricants, NSAIDs and other ophthalmic categories. Its product catalogue specifically includes multiple suspension formulations.  

Businesses can review the EyeKare ophthalmic product portfolio to assess TwoBrieye, NEPEYE OD and MOXIEYE-LP GEL alongside the company’s other ophthalmic solutions. This broader review can help distributors, hospitals, clinics and pharmaceutical businesses identify formulations relevant to their product requirements. 

Ophthalmic Suspension Supply for Nagpur

Nagpur’s hospitals, eye-care centres, pharmacies and pharmaceutical distribution channels create a market for specialized ophthalmic products. For businesses supplying these channels, selecting a manufacturer with clearly defined formulations and established ophthalmic capabilities can support more structured procurement and portfolio planning. 

An ophthalmic suspension manufacturer should be able to support the technical requirements of the specific product, from formulation and quality control through packaging and supply. EyeKare’s range of sterile suspension products provides businesses with several examples of specialized ophthalmic dosage forms within one focused portfolio. 

Why Consider EyeKare Kilitch as an Ophthalmic Suspension Manufacturer?

EyeKare Kilitch combines a dedicated ophthalmology focus with an in-house manufacturing approach and a portfolio that includes multiple ophthalmic suspensions. Its stated manufacturing infrastructure, research and quality-control capabilities and range of specialized eye-care products provide relevant factors for businesses evaluating a supplier. 

For organizations evaluating EyeKare ophthalmic suspension manufacturing, the presence of preservative-free, combination and single-active suspension products provides useful evidence of portfolio breadth. Supplier selection should ultimately consider the exact product specification, regulatory documentation, quality requirements and intended market. 

Conclusion

Ophthalmic suspensions require specialized formulation and manufacturing controls to support consistent, sterile products. EyeKare’s official portfolio includes TwoBrieye, NEPEYE OD and MOXIEYE-LP GEL, covering different ophthalmic suspension formulations and therapeutic applications. 

For businesses searching for Ophthalmic Suspension Manufacturer in Nagpur, EyeKare Kilitch offers a specialized ophthalmology portfolio supported by stated in-house manufacturing capabilities and quality-focused operations. Its suspension range can be evaluated according to the specific formulation, documentation and supply requirements of the intended healthcare market. 

Subscribe Our News Letter!

Subscribe to the EyeCare newsletter to receive updates on the latest developments, events and innovations in ophthalmology.

EyeKare Kilitch  is an innovative pharmaceutical company that discovers, develop, manufactures and market a broad range of healthcare products.

Facebook-f Instagram

Useful links

Contact Us

+91-22-6137 2222

info@eyekare.in

902-B, Godrej Coliseum, Behind Everard Nagar, Off. Eastern Express Highway, Nr. Priyadarshani Circle, Sion (E.), Mumbai - 400 022. INDIA.

© Copyright 2024 – EyeKareKilitch

Group of Companies